Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

O
Oak M. H. - Thrombin induces the expression of pro-MMP-2 and its conversion to MMP-2 in vascular smooth muscle cells: both responses are inhibited by red wine polyphenols
Obadia J. F. - Identification and characterisation of MIP-1b and VE-Cadherin as important markers of acute rejection after human heart transplantation
Obergfell A. - The scaffold function of b3 integrins regulates integrin signaling
Obert B. - Stability of 19 mutated recombinant von Willebrand factor to von Willebrand factor-cleaving protease (ADAMTS13)
  - Identification of seven new candidate mutations of ADAMTS13 gene in four French families related to congenital thrombotic thrombocytopenic purpura
  - Identification of the bitiscetin-binding site on the von Willebrand factor A3-domain. Comparison to the collagen-binding site
Obitko Pludowska A. - Immune tolerance induction in the treatment of children with haemophilia A complicated by factor VIII inhibitor
O'Brien L. - A type 2A (Group II) von Willebrand disease mutation (Leu1503Glu) associated with a minimal loss of high molecular weight von Willebrand factor (VWF) multimers
O'Brien L. A. - Clear familial co-segregation of the type 1 von Willebrand disease phenotype and VWF haplotypes in the Canadian type 1 VWD study
O'Brien L. - An in silico analysis of type 2 A von Willebrand disease mutations
  - An ancient von Willebrand Disease (VWD) mutation that associates with a common haplotype in ~14% of type 1 VWD patients
O'Brien P. - Coagulation factor content of solvent/detergent plasma compared to fresh frozen plasma
Obrig T. G. - Shiga toxin interactions with platelets: differential effects of anti-coagulants and platelet isolation procedures
  - Release of chemokines by monocytes and endothelial cells upon exposure to Shiga toxin and LPS: potential roles in platelet activation
Obser T. - Comparative expression of recombinant wildtype and mutant von Willebrand factor cleaving protease ADAMTS13
  - Splice site mutations of the von Willebrand factor gene in patients previously diagnosed with von Willebrand disease type 1
Obst U. - The active conformations of Factor VIIa and Factor IXa: biochemical, biophysical, chemical and crystallographic studies
Ocariz J. - ‘Red, white and blue’: a new method to inactivate blood-borne pathogens a
Ocio E. - Massive life-threatening lung hemorrhage and successful treatment with recombinant human-activated FVIIa concentrates
Ockelford P. - Protein Z-dependent protease inhibitor (ZPI) deficiency: a new thrombotic risk factor?
  - Correction of coagulation, as measured by the thromboelastogram, with low dose recombinant VIIa treatment in a patient with a factor VIII inhibitor
  - The rate of thrombus resolution following treatment of DVT is related to the site and the precipitating cause of thrombosis
Ocmant A. - The clinical relevance of anti-b2-GP1 antibodies assays in the presence of antiphospholipid antibodies and/or lupus anticoagulant
O'Connor S. E. - Thrombolysis induced by streptokinase or recombinant plasminogen activator (rt-PA) is improved by SSR182289A, a direct orally active thrombin inhibitor, in rabbit models of thrombosis
O'Connor M. N. - Difference in binding of human and murine glycoprotein VI to collagen-related peptide and fibrillar collagen
O'Connor M. - Platelet glycoprotein VI has evolutionary conserved immunoglobulin domains, but a highly polymorphic stem and cytoplasmic domain
O'Connor M. N. - Human glycoprotein VI: identification and blockade of the collagen-binding surface
Oda E. - Various ratio of n-3/n-6 polyunsaturated fatty acid alters the tendency of thrombosis and progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse
Odone-Filho V. - Venous thromboembolism (VTE) in children: a series of cases from a pediatric Brazilian cohort
O'Donnell M. - Evaluation of a venous-return assist device (venowave) to treat post-thrombotic syndrome: a phase II study
O'Donnell M. - A systematic review of venous thromboembolism and long distance travel: strength of association and evidence for prevention
O'Donnell J. - Coagulation factor content of solvent/detergent plasma compared to fresh frozen plasma
  - Use of TEG® as a global measure of thrombogenicity in thrombophilia screening
O'Donovan G. - Plasma fibrinogen, factor IIXa and other coronary heart disease risk factors in exercising and nonexercising men aged 30–45 years
Koenen R.R. - Functional impairment of protein S in carriers of the prothrombin G20210A mutation
Offerman E. H. - Tissue-type plasminogen activator (t-PA) gene deletion in apoE3-Leiden mice delays progression of cholesterol-induced atherosclerotic lesion
Offermanns S. - Activation of RhoA and Rac through Gq- and G12/G13-mediated pathways in mouse and human platelets stimulated by TXA2 or ADP
Ofosu F. A. - PAR-1 (1–41) and SFLLRN independently propagate platelet activation
  - Altered regulation of in vivo coagulation in orthopedic patients prior to knee or hip replacement surgery
Ofosu F. A. - Statin regulation of extrinsic thrombin generation
Ofosu F. A. - Activation of human platelets by sub-nanomolar alpha-thrombin requires participation of both PAR-1 and PAR-4
Ogata Y. - VWF/FVIII concentrate enhances platelet adhesion onto a surface of immobilized collagen under flow conditions
Ogawa T. - Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747, a novel P2Y12 receptor antagonist
  - Anti-platelet and anti-thrombotic effects of CS-747, a novel P2Y12 receptor antagonist, in combination with aspirin
  - Effects of CS-747, a novel P2Y12 receptor antagonist, on cerebral and peripheral arterial occlusive diseases in rats
Oger E. - Oral not transdermal estrogen replacement therapy is associated with venous thromboembolism risk
Ogleby J. - Thrombotic potential may be increased in healthy individuals with a two-generation family history of premature myocardial infarction
O'Grady A. - Protein Z-dependent protease inhibitor (ZPI) deficiency: a new thrombotic risk factor?
Oguni S. O. - Usefulness of fully automated measurement of reticulated platelet using the whole blood
Oh P. - Final results from the Canadian hemophilia dose escalation prophylaxis trial
Oh H. J. - A collaborative study to establish a Korea National Biological Standard for antithrombin III concentrate
Oh D. - Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
Oh-I C. - Mechanism of decreased plasma von Willebrand Factor-cleaving metalloproteinase activity in patients with collagen vascular disease
Ohkura N. - Oxidation products of common phospholipid specifically impair the activity and the reactivity of tissue factor pathway inhibitor
Ohnishi Y. - Successful argatroban-anticoagulant management for left ventricular assist system implantation in two patients with heparin-induced thrombocytopenia type II
Ohnishi T. - Zinc chelation by histidine-rich glycoprotein is essential for its interaction with coagulation and fibrinolysis factors and its ability to enhance fibrinolysis
Ohno Iwashita Y. - Cholesterol-microdomains in platelet adhesion and aggregation
Ohsugi T. - Isolation and administration effect of fibrinolysis accelerating substance (FAS) in the fermented soybean food, natto
Ohta M. - Remnant-like lipoprotein particles potentiate platelet activation under high shear stress assessed by the ‘collagen column’, filled with collagen-coated small beads
Ohta Y. - Impaired flow-mediated vasodilation in vivo and reduced shear-induced platelet reactivity in vitro in response to nitric oxide in prothrombotic, stroke-prone spontaneously hypertensive rats
Ohta K. - C-reactive protein induces the expression of tissue factor and interleukin-8 in the lung
Ohta M. - Sphingosine 1-phosphate-related metabolism in the blood
Ohtake S. - Three novel point mutations that cause severe factor XI deficiency in two unrelated Japanese families
Ohyama S. - Non-lysine-analog plasminogen modulators: promotion of autocatalytic generation of plasmin(ogen) fragments with angiostatin-like activity and inhibition of tumor growth in vivo
Oida K. - Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family
Oida K. O. - Oxidized phospholipids in oxidized LDL down-regulate thrombomodulin transcription in vascular endothelial cells through a decrease in the binding of RAR
Oida K. - Ligand for peroxisome proliferator-activated receptor-a (PPARa) Down-regulates tumor necrosis factor - a-induced pro-coagulant activation of tissue factor through inhibition of ap-1-dependent gene transcription in human endothelial cells
Oike Y. - Activated protein C induces angiogenesis in vivo and in vitro
Ojalvo A. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Okada K. - Regulation of plasminogen activation at the surfaces of mouse hepatocyte
Okada M. - Nonmethylated status of promoter CpG islands in human tissue factor gene
Okada K. - Lack of a2-antiplasmin promotes endothelial healing via over-release of VEGF after vascular injury in mice
  - Transcription of plasminogen gene in mouse hepatocytes is regulated by cellular density
  - Lack of a 2-antiplasmin promotes endothelial healing via over-release of VEGF after vascular injury in mice
Okajima K. - Stimulation by antithrombin of sensory nerve-mediated anti-inflammatory pathway in rats
  - Activated protein C induces angiogenesis in vivo and in vitro
  - Antithrombin suppresses endotoxin-induced hypotension through the effect of calcitonin gene-related peptide
Okamoto A. - Assessment of diagnostic procedures, ratio method and posterior probability method, for protein C deficiency using protein C and antithrombin activities
Okazaki T. - A novel ELISA method for soluble fibrinogen and fibronectin complexes (FG–FN) in normal adult's and DIS patient's plasma
Okuda D. - Characterization and preliminary crystallographic studies of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus
Okuda D. - Crystal structure of a disintegrin from snake venom containing a cell adhesion recognition sequence RGD
  - A new gene structure of disintegrin family: a subunit of dimeric disintegrin has short coding region
Okumura Y. - Tissue factor pathway inhibitor is highly susceptible to chymase-mediated proteolysis
Oldenburg J. - Analysis of mRNA in a panel of hemophilia A patients with no detectable mutation in the coding regions of the factor VIII gene
  - Response to DDAVP in mild/moderate hemophilia A patients according to the underlying factor VIII genotype
  - Epitopes of factor VIII inhibitors analyzed by peptide-arrays
  - Genetic profiling of 20 patients with FVII deficiency by dHPLC and sequence analysis: detection of 7 novel mutations
  - Genetic mechanisms underlying the clinical manifestation of hemophilia A in females
Oldenburg J. - Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
Oldenburg J. - The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
Oldenburg J. - Genetic basis of inhibitor development
Oldenburg J. - Mutation profiling in congenital FXIIIA deficiency: detection of 6 novel mutations
Olds R. J. - Variation in antithrombin helix A impedes secretion and function of the inhibitor
Olds R. - Factor V Gly2112Asp, a C2-domain variant, is associated with severe deficiency and a bleeding tendency
Olds R. - The anti-thrombin variant -6Arg is a silent mutation
Oliveira L. C. O. - Psychologic impact of thrombophilia screening in asymptomatic relatives of carriers of prothrombotic mutations
Oliveira L. C. O. - Thrombotic risk in first-degree relatives of factor V Leiden (FVL) and factor II G20210A carriers
Oliveira M. H. C. F. - Ligneous conjunctivitis: report of two cases
Oliveira G. - Effects of cardiopulmonary bypass on platelet activation markers
Oliveira S. C. - Partial results of the incidence of Thrombocytopenia Induced Heparin
Oliveira V. - Factor VII deficiency and stroke: case report
Oliver A. - The 46C®T polymorphism in the F12 gene as a risk factor for venous thrombosis: association after linkage analysis
Oliver J.A. - Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system
Oliver A. - Risk of ischemic stroke (IS) associated with plasma levels of thrombin-activatable inhibtor fibrinolysis (TAFI)
  - The 46C®T polymorphism in F12 gene is a risk factor for coronary artery disease
  - The 46C®T polymorphism in the F12 gene is a risk factor for ischemic stroke
Olivieri O. - Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis
  - Low vitamin B6, markers of inflammation, and coronary artery disease
Ollikainen E. - Relation of prothrombotic platelet polymorphisms to the first manifestation of Coronary Artery Disease in middle-aged males
Ollivier V. - Fractalkine/CX3CL1 production by human aortic smooth muscle cells impairs monocyte procoagulant and inflammatory responses
Ollivier V. - The Asp299Gly polymorphism of Toll-like receptor 4 as a genetic risk factor for acute coronary events
Olschewski A. - Determination of direct thrombin inhibitors like hirudin in plasma – Comparison of the Ecarin Chromogenic Assay (ECA) with the Ecarin Clotting Time (ECT) and the Activated Partial Thromboplastin Time (APTT)
Olsen J. O. - Association of the -159 C-to-T polymorphism in the CD14 promoter with variations in serum lipoproteins in healthy subjects
Olsen B. - Prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after major abdominal surgery: the FAME study
Olsen E. H. N. - Comparative response of plasma VWF in normal and von Willebrand disease dogs to up-regulation of VWF mRNA by Interleukin-11 vs. Weibel–Palade body release by Desmopressin (DDAVP)
Olsen J. O. - The relationship between sh-CRP and reactivity of monocytes and various blood parameters known to play an important role in atherogenesis
  - Encrypted tissue factor (TF) in circulating human monocytes of healthy individuals
Olsen O. H. - L305V/S314E/K337A/F374Y-Factor VIIa has dramatically enhanced intrinsic activity
Olson R. E. - Tracking the uptake of evidence: two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolism
Olson S. T. - Anti-thrombin III phenylalanines 122 and 121 contribute to its high affinity for heparin and conformational activation
Olson R. E. - D-dimer for the exclusion of acute deep venous thrombosis and pulmonary embolism: a systematic review
Olsson E. - PECAM-1 expression in adherent platelets differs from that of thrombi during human microvascular anastomosis
Olsson C. G. - A randomized placebo controlled trial of dalteparin for the prevention of venous thromboembolism in 3706 acutely Ill medical patients: the PREVENT medical thromboprophylaxis study
Olsson P. - Surface deposited fibrin activates factor XII and the intrinsic coagulation pathway
Oltean G. - Use of recombinant activated factor VII (NovoSeven) in patients with liver cirrhosis
O'Morain C. - Randomized trial of tinzaparin, a low molecular weight heparin (LMWH) vs. placebo in the treatment of mild-to-moderately active ulcerative colitis
on behalf of FCSA  - Perioperative management with low molecular weight heparin (LMWH) of patients (pts) on long-term oral anticoagulant therapy (OAT) undergoing major surgery: a multicenter prospective observational study
on behalf of PROSIT, Protein S Italian Team, Italy  - Genetically defined protein S (PS) deficiency is associated with venous thrombosis
On behalf of The Dali-study Group  - Atorvastatin strongly reduces C-reactive protein, but shows less marked effect on other prognostic inflammatory markers
on behalf of The THRIVE Treatment Study Inv, Netherlands  - Efficacy and safety of the oral direct thrombin inhibitor ximelagatran compared with current standard therapy for acute symptomatic deep vein thrombosis, with or without pulmonary embolism: a randomized, double-blind, multinational study
Ondrejka P. - Is infection a risk factor of acute ischemic stroke?
O'Neill S. - A role for the thiol isomerase activity of a IIbb 3 in receptor clustering
O'Neill D. A. - Fibrinogen gene mutations causing dysfibrinogenemia are associated with variable phenotypes
O'Neill K. F. - Coagulation activation markers in atrial fibrillation: dose-dependent correlation with warfarin therapy
O'Neill C. - An analysis of the platelet transcriptome using commercial microarrays
O'Neill S. - Functional modulation of platelet aIIbb3 by its endogenous thiol isomerase activity
O'Neill K. F. - Population prevalence of atrial fibrillation and factors associated with use of warfarin
Ongaro A. - The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
Onimaru M. - Platelet-derived growth factor receptor-alpha signaling is required for therapeutic angiogenesis induced by fibroblast growth factor-2
Onimaru M. - Involvement of VEGF-C/flt-4 system in therapeutic angiogenesis of FGF-2 gene transfer in murine ischemic hind limb
Oniszh K. - Compression ultrasound in diagnosis of asymptomatic deep venous thrombosis
Onley C. M. - The low frequency allele of glycoprotein VI raises the threshold for platelet activation by collagen and collagen-related peptides
Onley C. M. - Functional significance of single-nucleotide polymorphisms in the glycoprotein VI gene
Ono N. - Anti-thrombotic effects of ER112787, a novel, nonpeptide thrombin receptor (PAR-1) antagonist, in a photochemically induced thrombosis model using guinea pigs
Ontachi Y. - Three novel point mutations that cause severe factor XI deficiency in two unrelated Japanese families
  - Rituximab reduces anti-phospholipid antibody (APA) titers and improves hypercoagulability in patients with anti-phospholipid syndrome (APS)
  - Is an antithrombin substance (aFIIa) more hemorrhagic compared with an anti-factor Xa (aFXa) aent?: Differential inhibitory effects of these two agents against platelet activation
Onundarson P. T. - Bleeding symptoms, von Willebrand factor (vWF) and von Willebrand's disease in Icelandic teenagers. The Bleeding Assessment in Teenagers (BAT) Study
Onundarson P. T. - Platelet dysfunction in Icelandic teenagers. The bleeding assessment in teenagers (BAT) study
Ooi Y. C. - Investigations on the regulation of vascular smooth muscle cell migration by tissue factor (CD142)
Oosthuizen W. - The effect of refined and red palm olein compared to sunflower oil on lipids and homeostatic factors in hyperfibrinogenemic patients
Opatrny L. - Specific and nonspecific antiphospholipid antibodies in recurrent fetal loss: a meta-analysis
Opitz A. - cGMP regulates thrombopoietin-induced CD34+ human stem cell proliferation and differentiation into megakaryocytes
Opolski G. - Activity of endogenous fibrinolytic system induced by exercise ECG test in patients with previous positive ECG-exercise test but without essential atherosclerotic changes in coronaries during angiography
Oppenheimer C. - The effects of folic acid supplements on coagulation status in pregnancy
  - Changes in thromboelastography in low-risk women in the puerperium
Orbe J. - Pravastatin modulates the cytokine-induced endothelial expression of PGE2: A novel anti-inflammatory mechanism of cholesterol-lowering drugs
  - Proteolytic pattern in advanced atherosclerotic human lesions: relation to vascular bed, plaque features, and cardiovascular risk factors
  - Circulating prostaglandin E2 is associated with high risk of coronary heart disease in asymptomatic subjects: a novel inflammatory marker of subclinical atherosclerosis
  - The endothelial expression of pai-1 by Angiotensin II is dependent on the 4 g/5 g polymorphism: clinical and therapeutic implications
Ordinas A. - Effect of antiphospholipid antibodies in the activation of the contact complex: importance in the obstetric complications of the antipospholipid syndrome
  - Polymorphisms of platelet glycoproteins Ib-a and Ia/IIa: relationship with early arteriosclerosis and arterial thrombosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus
  - Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model
  - Granulocyte colony-stimulating factor exerts a pro-inflammatory effect on endothelial cells through activation of p38 MAPK
Ordoñez-Llanos J. - A quantitative trait locus on chromosome 11 is the major genetic determinant of homocysteine plasma levels. Results from the GAIT Project
O'Reilly D. - Effects of age, sex, and oral contraceptive use on hemostatic, fibrinolytic and inflammatory variables: cross-sectional population survey
Orel E. B. - Dynamics of changes of parameters of a hemostasis in patients with sepsis
  - Laboratory (on base coagulological tests) it is latent proceeding hematogenous thrombophilias
Orfeo T. - Systemic enzymatic activity in blood?
Orlacchio A. - Lysosomal beta-N-acetylhexosaminidase is a primer of platelet activation
Orliaguet G. - Anti-thrombin F229L: a new homozygous variant leading to spontaneous anti-thrombin polymerization in vivo and severe childhood thrombosis
Orm S. - Randomized trial of tinzaparin, a low molecular weight heparin (LMWH) vs. placebo in the treatment of mild-to-moderately active ulcerative colitis
Orntoft T. F. - The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction
Orringer E. P. - CD47 stimulated sickle erythrocytes adhere to activated monocytes via a novel contribution of the a 4b 1 integrin from each cell type
Orsini Federici M. - Impairment of fibrynolytic capacity in experimentally induced ketoacidosis in continuous subcutaneous insulin infusion patients
Ortel T. L. - Sensitivity and specificity of the abnormal optical waveform profile in the prothrombin time from patients with antiphospholipid antibodies
  - Inhibition of factor VIII binding to phospholipids by single-chain variable domain fragments indicates that F2200 plays a more important role than M2199 in membrane-binding
Ortel T. L. O. - Clinical trial to evaluate the safety and efficacy of an Internet-based system for supervised self-management of oral anti-coagulant therapy
Ortel T. L. - Annexin A5 resistance in the antiphospholipid (aPL) syndrome
Ortin R. - Risk of ischemic stroke (IS) associated with plasma levels of thrombin-activatable inhibtor fibrinolysis (TAFI)
  - Genetic dissection of thrombin-activatable fibrinolysis inhibitor (TAFI)
Osa A. - Lipoprotein (a) levels and isoforms and fibrinolytic parameters in young survivors of myocardial infarction with and without peripheral artery disease
Osada M. - Sphingosine 1-phosphate-related metabolism in the blood
Osadchenko I. A. - Impairment of morphology and NO release in cultured endothelial cells from rabbit coronary vessels following total irradiation by external CO60
Osakabe M. - Transition of treatment with i.v. Argatroban to Phenprocoumon and Acencoumarol
  - Interaction of thrombolytic agents with argatroban: pharmacological implications
  - Effects of argatroban alone or in combination with phenprocoumon or acenocoumarol on aPTT and ecarin clotting time
  - Influence of argatroban alone and combined with oral anticoagulants on the assessment of coagulation factors
  - Serine proteases–mediated serotonin release and its inhibition by argatroban and other direct thrombin inhibitors: Implications in the control of thrombogenesis
  - Treatment of patients with a history of heparin-induced thrombocytopenia (HIT type II) and of anti-lepirudin antibodies with argatroban or lepirudin
  - Effects of argatroban in combination with oral anticoagulation on thrombin generation
Osanto S. - Incidence of thrombosis in gastro-esophageal cancer: a cohort study of 649 patients
O'Shaughnessy D. F. - Factor VII Padua: diagnosis based on differential laboratory tests
O'Shaughnessy D. O. - Residual platelet function can be detected in patients on antiplatelet therapy using novel Hemoscope reagents and standard Thrombelastograph® (TEG®)
O'Shaughnessy D. - Baseline characteristics, risk factor profile and outcomes of patients treated for venous thromboembolic disease with low molecular weight heparin (enoxaparin) – the Venous Thromboembolism Registry (VERITY)
O'Shaughnessy D. F. - Platelet glycoprotein Iba VNTR polymorphisms: association with thromboembolic diseases
O'Shaughnessy D. F. - Does thromboelastography demonstrate hypercoagulability in patients with both a clinical history of thrombosis and the lupus anti-coagulant antibody?
O'Shaunessey D. - An ancient von Willebrand Disease (VWD) mutation that associates with a common haplotype in ~14% of type 1 VWD patients
O'Shea S. - Clinical trial to evaluate the safety and efficacy of an Internet-based system for supervised self-management of oral anti-coagulant therapy
Osip J. - Successful liver transplantation in a hemophilia A patient with high titer factor VIII inhibitor
Osmanovic N. - Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo
  - Soluble tissue factor released by cultured human umbilical vein endothelial cells is microparticle-associated and triggers thrombus formation in vivo
Osswald M. - Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report
Ostrowska J. - Calpain inhibitor calpeptin enhances the activity of the 20S proteasome in intact and calcium ionophore-stimulated platelets
Ostrowska H. - Calpain inhibitor calpeptin enhances the activity of the 20S proteasome in intact and calcium ionophore-stimulated platelets
Ostrowska H. - Effects of proteasome inhibitors on alpha-granule secretion and microparticle formation during thrombin-induced platelet activation
Ostrowska J. K. - Effects of proteasome inhibitors on alpha-granule secretion and microparticle formation during thrombin-induced platelet activation
O'Sullivan A. - The effect of ABO and Secretor genotypes on thrombin generation
O'Sullivan G. - Shear-induced activation of metastatic cells is enhanced by the platelet secreteome and inhibited by aspirin
Otahalova E. - Influence of oxidatively modified low-density lipoproteins on platelet function
Otero A. - Retrospective study of acquired factor VIII inhibitor
Otero A. M. - Association between recurrent pregnancy loss and prothrombotic gene polymorphisms
Othman M. - An ancient von Willebrand Disease (VWD) mutation that associates with a common haplotype in ~14% of type 1 VWD patients
Oton A. B. - Thrombotic thrombocytopenic purpura in a patient with acquired vWF protease (ADAMTS13) deficiency was heralded by variable stimuli and lacked a good correlation between platelet counts and vWF protease levels
Otsuguro K. - Effects of CS-747, a novel P2Y12 receptor antagonist, on cerebral and peripheral arterial occlusive diseases in rats
Ott I. - Tissue factor stimulates migration by activation of the mitogen-activated proteinkinase p38 and the GTPase Rac1
Ott I. - Proteolysis of tissue factor pathway inhibitor-1 on circulating microparticles after thrombolysis in acute myocardial infarction contributes to thrombin formation
Otte J. - Anti-endothelial cell antibodies (AECA): cDNA-based antigen screening
Otte J. - Gene expression analysis in platelets: use of a PCR-based RNA amplification technique for generating suitable amounts of cDNA
Otten J. M. M. B. - Malignancy and low-molecular weight-heparin therapy: the MALT trial
Otten J. M. M. B. - Subsequent diagnosis of malignancy in patients presenting with an idiopathic venous thromboembolism – a number needed to screen and decision analysis based on the results of a prospective study
Otterdal K. - Interleukin-7-mediated inflammation in unstable angina – possible role of chemokines and platelets
Otterdal K. - Solubilization of CD40L (CD154) from platelets after activation and secretion: proteolysis directly on the platelet surface or after receptor-mediated internalization?
oude Egbrink M. G. A. - In vivo involvement of ADP in thromboembolism through its receptors P2Y1 and P2Y12
Oudemans-Van Straaten H. M. - Lepirudin anti-coagulation in critically ill patients with (suspected) heparin-induced thrombocytopenia and thrombosis
Ounnoughène N. - Treatment of patients with inhibitors with FEIBA: the French experience from 1995 to 1999
Oury C. - Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype
Oury C. - Glycoprotein Ib and integrin a IIbb 3 contribute to GPVI-dependent vWF-collagen induced thrombus formation under flow
  - P2X1-induced activation of Ca2+ calmodulin leads to myosin light chain and ERK2 phosphorylation in human platelets
Ouwehand W. H. - The low frequency allele of glycoprotein VI raises the threshold for platelet activation by collagen and collagen-related peptides
  - The epitope of the CD109 monoclonal antibody 8A3 overlaps with the epitope of Gov antibodies: implications for Gov antibody detection
  - The use of synthetic triple helical peptides to define a recognition motif in collagen III for human platelet receptor, Glycoprotein VI
  - Functional significance of single-nucleotide polymorphisms in the glycoprotein VI gene
  - Teicoplanin-dependent platelet antibodies as a cause of severe thrombocytopenia
  - Interplay of glycoprotein Iba, integrin a2b1 and glycoprotein VI is required for human thrombus formation under flow
Ouwehand W. - Loss of tolerance for platelet glycoprotein VI by vaccination of Balb/c mice with a GPVI-tetanus toxoid fusion protein
Ouwehand W. H. - Platelet CD109: evidence for a transmembrane homologue on monocytes?
  - Difference in binding of human and murine glycoprotein VI to collagen-related peptide and fibrillar collagen
  - Human glycoprotein VI: identification and blockade of the collagen-binding surface
  - Platelet glycoprotein VI has evolutionary conserved immunoglobulin domains, but a highly polymorphic stem and cytoplasmic domain
Ovanesov M. V. - Comparative study of the effect of recombinant factor VIIa on clot growth and thrombin generation in normal and hemophilia A plasma in vitro
Ovanesov M.V. - The mechanism of action of high-dose factor VIIa in preventing bleeding in hemophilia. Computational simulation studies
Ovanesov M. - Factor IXa/factor VIIIa-dependent pathway is responsible for the growth of clot away from the fibroblast monolayer surface
Ovary C. - Thrombolytic therapy in acute ischemic stroke: same method, same team, different drug
Oviedo S. A. - Preparation of prothrombin complex concentrate (PCC) at intermediate scale: first experience in Argentina
Oviedo S. - Development, scale up and characterization of the first regional high purity Factor VIII: the Argentinean experience
Ovissi L. - IgG-antibodies (IgG-Ab) against beta-2-glycoprotein I (b2-GPI) are associated with an increased risk for thrombotic events (TE) in patients (pts) with the lupus anticoagulant (LA)
Owaidah T. - Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies
Owen J. - A simplified assay for VWF cleaving protease (ADAMTS-13) activity and inhibitor in plasma
Owen W. G. - Occurrence and management of abciximab induced pseudothrombocytopenia
Owens E. - Total fibrin ‘super glue’ components from human plasma: a new blood banking procedure
Owens W. - Revisiting human plasma-derived factor VIII
Owens D. - Promotion of thrombin generation at low FVIII concentrations by FIXa
Owings J. T. - Protein C levels in critically ill ICU patients: differences seen between patients with and without sepsis
  - Effect of short-term, low-fat vegetarian diet and walking program on coagulation
Oyen F. - Splice site mutations of the von Willebrand factor gene in patients previously diagnosed with von Willebrand disease type 1
  - Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
  - Comparative expression of recombinant wildtype and mutant von Willebrand factor cleaving protease ADAMTS13
Oyslender M. - Cost-effectiveness of venous thromboembolism prophylaxis after total hip replacement
  - Thrombosis risk factor assessment in surgical patients: compliance with chest consensus guidelines
Ozaki Y. - Sphingosine 1-phosphate-related metabolism in the blood
  - Mechanisms of platelet retention in the collagen-coated bead columns
  - Coagulation factor XII activity, but not an associated common genetic polymorphism, is linked to recurrent miscarriage
  - Platelet endothelial cell adhesion molecule-1 (PECAM-1) of platelets is cleaved under high shear stress
Ozaki Y. - Signaling through GPIb with reference to PI 3-kinase and Src
Ozaki Y. - Differential role of phosphatidylinositol 3-kinase in glycoprotein Ib-mediated platelet activation
  - Interaction of the glycoprotein (GP) Ib-IX/V complex with the platelet collagen receptor GPVI
  - Remnant-like lipoprotein particles potentiate platelet activation under high shear stress assessed by the ‘collagen column’, filled with collagen-coated small beads
Ozaki M. - Differences in perioperative coagulation between Japanese and other ethnic groups undergoing laparoscopic cholecystectomy
Ozawa T. - Intracellular behavior of anti-thrombin Morioka (Cys95Arg), a mutant protein causing type I deficiency: escape from intracellular protein degradation systems and accumulation within newly formed Russell's body-like structures
Ozcan M. - The relation of activated protein C resistance with ABO blood groups
Ozdemir V. - Evidence for a functional role of 5-hydroxytryptamine-2 A receptor gene (HTR2A) polymorphism (T102C) in human platelet aggregation
Ozdener F. - Evidence for a functional role of 5-hydroxytryptamine-2 A receptor gene (HTR2A) polymorphism (T102C) in human platelet aggregation
Ozeki Y. - Platelet-derived microparticle preparations for enzyme-linked immunoassay, and the high PDMP level detected in unstable angina patients
Ozelo M. C. - Alternative second-line treatment for chronic immune thrombocytopenic purpura with sulphasalazine
Ozelo M. C. - A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
  - Oral anti-coagulation and dental extraction
Ozyurek E. - Assessment of the role of various genetic risk factors in development of childhood cerebral thrombosis